2955243-69-1
2955243-69-1
Chemical Structure
GP130-IN-1
- CAS No.: 2955243-69-1
- Formula:C21H10F5NO3
- Molecular Weight:419.30
InChIKey: WGEDVLIIOFBHLD-UHFFFAOYSA-N
SMILES: O=C(N1C(C2=CC=C(O)C=C2)=CC3=C1C=CC(O)=C3)C4=C(F)C(F)=C(F)C(F)=C4F
Biological Activity: GP130-IN-1 (compound 49) is a potent GP130 inhibitor with significant in vitro antitumor activity and higher selectivity than Bazedoxifene (HY-A0031). GP130-IN-1 induces ultrastructural changes in cells, causing cell cycle arrest in the G0/G1 phase in a time-dependent manner and triggering apoptosis and autophagy. GP130-IN-1 can be used in the study of triple-negative breast cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GP130-IN-1 | GP130-IN-1 (compound 49) is a potent GP130 inhibitor with significant in vitro antitumor activity and higher selectivity than Bazedoxifene (HY-A0031). GP130-IN-1 induces ultrastructural changes in cells, causing cell cycle arrest in the G0/G1 phase in a time-dependent manner and triggering apoptosis and autophagy. GP130-IN-1 can be used in the study of triple-negative breast cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
